Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-176
Closed 632
2020
Q1
$0 Sell
176
-6,414
-97% -$84.2K ﹤0.01% 788
2019
Q4
$154K Sell
6,590
-1,275
-16% -$27.3K 0.02% 340
2019
Q3
$181K Buy
7,865
+360
+5% +$8.24K 0.03% 352
2019
Q2
$193K Buy
7,505
+694
+10% +$21.6K 0.03% 336
2019
Q1
$247K Buy
6,811
+1,879
+38% +$64.4K 0.04% 316
2018
Q4
$142K Buy
4,932
+47
+1% +$2.03K 0.03% 315
2018
Q3
$320K Sell
4,885
-69
-1% -$4.47K 0.05% 283
2018
Q2
$324K Sell
4,954
-47
-0.9% -$2.95K 0.05% 278
2018
Q1
$275K Buy
+5,001
New +$297K 0.04% 311
2015
Q4
Sell
-7,240
Closed -$233K 668
2015
Q3
$233K Sell
7,240
-1,594
-18% -$61.1K 0.02% 601
2015
Q2
$487 Buy
8,834
+5,783
+190% +$368K 0.07% 269
2015
Q1
$170 Buy
+3,051
New +$192K 0.02% 405

Other funds holding OVV

Arden Trust's OVV Position: Q2 2020 in Review

Arden Trust sold out of Ovintiv (OVV) in Q2 2020, closing a stake of 176 shares.

Arden Trust first reported a position in OVV in Q1 2015 and held it in 12 quarters. The position peaked at $324K in Q2 2018. 264 funds tracked by Wall St. Rank hold OVV as of Q2 2020.

  • Arden Trust reported no remaining Ovintiv position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 176 Ovintiv shares in Q2 2020.
  • Arden Trust first reported a position in Ovintiv in Q1 2015 and held it in 12 quarters.
  • Arden Trust's Ovintiv position peaked at $324K in Q2 2018.
  • 264 funds tracked by Wall St. Rank held Ovintiv as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.